-
Archives
-
Further information
The ibvt is on board - € 26 million for new systems biology centre
The TU Braunschweig and the Helmholtz Centre for Infection Research came to an agreement to build a new systems biology centre. At the official signing ceremony on October 27th 2011, plans for the new "Braunschweig Integrated Centre for Systems Biology" - short BRICS were presented to the minister of science and education of Niedersachsen Prof. Johanna Wanka.
Photo (left to right): Prof. Dr. Martin Korte, vice president for strategic research development of the TU Braunschweig, Ulf Richter, Administrative Director of the HZI, Prof. Dr. Dirk Heinz, Research Director of the HZI, Prof. Dr. Johanna Wanka, Minister for Science and Culture of Lower Saxony, Prof. Dr.-Ing. Jürgen Hesselbach, President of the TU Braunschweig, Dietmar Smyrek, Permanent Vice President of the TU Braunschweig and Prof. Dr. Dieter Jahn, Chairman of the Board BRICS. (c) TU Braunschweig, Press and Communications.
Photo (left to right): Prof. Dr. Martin Korte, vice president for strategic research development of the TU Braunschweig, Ulf Richter, Administrative Director of the HZI, Prof. Dr. Dirk Heinz, Research Director of the HZI, Prof. Dr. Johanna Wanka, Minister for Science and Culture of Lower Saxony, Prof. Dr.-Ing. Jürgen Hesselbach, President of the TU Braunschweig, Dietmar Smyrek, Permanent Vice President of the TU Braunschweig and Prof. Dr. Dieter Jahn, Chairman of the Board BRICS. (c) TU Braunschweig, Press and Communications.
The BRICS facility will allow scientists and engineers to work closely together to provide answers for current issues in health and infections research using systems biology methods. This research will provide a better understanding of various diseases and might provide new insights for drug development of various pathogens. The BRICS is thus an important component of the translational Alliance Saxony (TRAIN), which bundles the know-how and infrastructure of university and extra-academic research for the development of active therapeutic agents for consistent further development of new potential agents and vaccines from basic research into pre-clinical and clinical development.
Photo (left to right): Prof. Dr. Dietmar Schomburg, Institute of Biochemistry and Biotechnology, TU Braunschweig, Prof. Dr. Phillip Tinnefeld, Institute of Physical and Theoretical Chemistry, TU Braunschweig, Prof. Dr. Michael Meyer-Hermann, Immunology, HZI, Dr. Ida Retter, coordinator of the BRICS, Dr. Lothar Jänsch, Cellular Proteomics, HZI, Prof. Dr. Kathrin Riedel, Microbial Proteomics, TU, Dr. Michael Jarek, Genome analysis, HZI, Prof. Dr. Christoph Wittmann, ibvt and Prof. Dr. Dieter Jahn, Institute of Microbiology, TU Braunschweig and spokesman of the BRICS board. (c) TU Braunschweig, Press and Communications.
Photo (left to right): Prof. Dr. Dietmar Schomburg, Institute of Biochemistry and Biotechnology, TU Braunschweig, Prof. Dr. Phillip Tinnefeld, Institute of Physical and Theoretical Chemistry, TU Braunschweig, Prof. Dr. Michael Meyer-Hermann, Immunology, HZI, Dr. Ida Retter, coordinator of the BRICS, Dr. Lothar Jänsch, Cellular Proteomics, HZI, Prof. Dr. Kathrin Riedel, Microbial Proteomics, TU, Dr. Michael Jarek, Genome analysis, HZI, Prof. Dr. Christoph Wittmann, ibvt and Prof. Dr. Dieter Jahn, Institute of Microbiology, TU Braunschweig and spokesman of the BRICS board. (c) TU Braunschweig, Press and Communications.
The state of Lower Saxony and the TU Braunschweig are jointly financing a total of 26 million for the new building. The BRICS will be constructed on the campus of the TU Braunschweig in close proximity of the Centrum of Biological Sciences. A total of four floors will provide room for laboratories and offices for accommodation of experimental and theoretical scientists. The BRICS will have second location on the campus of the HZI. With the construction of the new building the ibvt is getting about 650 m² of new laboratories and offices.
Combined with the center for pharmaceutical process technology which will also be constructed shortly, the BRICS will provide an important strategic addition for future research at the Institute of Biochemical Engineering. Ongoing ibvt projects like the development of tailor made cell factories for the production of biobased products and systems biology investigations of infectious processes will integrate ideally in the BRICS concept. ibvt developed “omics” technologies will provide a foundation for the new systems biology platform of the BRICS.